These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 3757391)
1. Influence of haemodialysis on the pharmacokinetics and haemodynamic effects of nifedipine during continuous intravenous infusion. Kleinbloesem CH; van Brummelen P; Woittiez AJ; Faber H; Breimer DD Clin Pharmacokinet; 1986; 11(4):316-22. PubMed ID: 3757391 [TBL] [Abstract][Full Text] [Related]
2. Nifedipine: influence of renal function on pharmacokinetic/hemodynamic relationship. Kleinbloesem CH; van Brummelen P; van Harten J; Danhof M; Breimer DD Clin Pharmacol Ther; 1985 May; 37(5):563-74. PubMed ID: 3987180 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of iloprost in patients with chronic renal failure and on maintenance haemodialysis. Hildebrand M; Krause W; Fabian H; Koziol T; Neumayer HH Int J Clin Pharmacol Res; 1990; 10(5):285-92. PubMed ID: 1706685 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and hemodynamic effects of long-term nifedipine treatment in hypertensive patients. Kleinbloesem CH; van Brummelen P; Faber H; Breimer DD J Cardiovasc Pharmacol; 1987 Feb; 9(2):202-8. PubMed ID: 2435999 [TBL] [Abstract][Full Text] [Related]
5. Nifedipine: kinetics and hemodynamic effects in patients with liver cirrhosis after intravenous and oral administration. Kleinbloesem CH; van Harten J; Wilson JP; Danhof M; van Brummelen P; Breimer DD Clin Pharmacol Ther; 1986 Jul; 40(1):21-8. PubMed ID: 3720176 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of nifedipine infusion in normal volunteers. Walley TJ; Heagerty AM; Woods KL; Bing RF; Pohl JE; Barnett DB Br J Clin Pharmacol; 1987 Jun; 23(6):693-701. PubMed ID: 3606929 [TBL] [Abstract][Full Text] [Related]
7. Haemodialysis does not affect the pharmacokinetics of nifedipine. Martre H; Sari R; Taburet AM; Jacobs C; Singlas E Br J Clin Pharmacol; 1985 Aug; 20(2):155-8. PubMed ID: 4041333 [TBL] [Abstract][Full Text] [Related]
8. Intravenous N-acetylcysteine during haemodialysis reduces the plasma concentration of homocysteine in patients with end-stage renal disease. Thaha M; Yogiantoro M; Tomino Y Clin Drug Investig; 2006; 26(4):195-202. PubMed ID: 17163251 [TBL] [Abstract][Full Text] [Related]
9. Influence of renal function on the pharmacokinetics and cardiovascular effects of nisoldipine after single and multiple dosing. van Harten J; Burggraaf J; van Brummelen P; Breimer DD Clin Pharmacokinet; 1989 Jan; 16(1):55-64. PubMed ID: 2706880 [TBL] [Abstract][Full Text] [Related]
10. Rate of increase in the plasma concentration of nifedipine as a major determinant of its hemodynamic effects in humans. Kleinbloesem CH; van Brummelen P; Danhof M; Faber H; Urquhart J; Breimer DD Clin Pharmacol Ther; 1987 Jan; 41(1):26-30. PubMed ID: 3802702 [TBL] [Abstract][Full Text] [Related]
11. Extracorporeal clearance of colistin methanesulphonate and formed colistin in end-stage renal disease patients receiving intermittent haemodialysis: implications for dosing. Jitmuang A; Nation RL; Koomanachai P; Chen G; Lee HJ; Wasuwattakul S; Sritippayawan S; Li J; Thamlikitkul V; Landersdorfer CB J Antimicrob Chemother; 2015; 70(6):1804-11. PubMed ID: 25698772 [TBL] [Abstract][Full Text] [Related]
13. Effect of food ingestion on nifedipine absorption and haemodynamic response. Hirasawa K; Shen WF; Kelly DT; Roubin G; Tateda K; Shibata J Eur J Clin Pharmacol; 1985; 28(1):105-7. PubMed ID: 3987781 [TBL] [Abstract][Full Text] [Related]
14. Nifedipine kinetics and dynamics during rectal infusion to steady state with an osmotic system. Kleinbloesem CH; van Harten J; de Leede LG; van Brummelen P; Breimer DD Clin Pharmacol Ther; 1984 Sep; 36(3):396-401. PubMed ID: 6467800 [TBL] [Abstract][Full Text] [Related]
15. An open-label, non-randomised, phase 1, single-dose study to assess the pharmacokinetics of ceftaroline in patients with end-stage renal disease requiring intermittent haemodialysis. Sunzel M; Learoyd M; Li J; Li Y; Ngo N; Edeki T Int J Antimicrob Agents; 2015 Dec; 46(6):682-8. PubMed ID: 26545441 [TBL] [Abstract][Full Text] [Related]
16. Rectal administration of nifedipine: haemodynamic effects and pharmacokinetics in hypertensives. Kurosawa S; Kurosawa N; Owada E; Matsuhashi N; Ito K J Int Med Res; 1987; 15(3):121-7. PubMed ID: 3609449 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of nisoldipine in renal dysfunction. Boelaert J; Valcke Y; Dammekens H; De Vriese G; Ahr G; Schurgers M; Daneels R; Bogaert MG Eur J Clin Pharmacol; 1988; 34(2):207-9. PubMed ID: 3383992 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of nifedipine in patients at steady state. Gutierrez LM; Lesko LJ; Whipps R; Carliner N; Fisher M J Clin Pharmacol; 1986; 26(8):587-92. PubMed ID: 3793948 [TBL] [Abstract][Full Text] [Related]
19. Intravenous nifedipine for prevention of myocardial ischaemia after coronary revascularization. Dupuis JY; Nathan HJ; Laganière S Can J Anaesth; 1992 Dec; 39(10):1012-22. PubMed ID: 1464126 [TBL] [Abstract][Full Text] [Related]
20. Total and free steady-state plasma levels and pharmacokinetics of nifedipine in patients with terminal renal failure. van Bortel L; Böhm R; Mooij J; Schiffers P; Rahn KH Eur J Clin Pharmacol; 1989; 37(2):185-9. PubMed ID: 2792174 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]